Together with our findings using the EGFR-AA construct, these data suggest a mechanism in which more migratory and metastatic breast cancer cells undergo an increased rate of nuclear rupture and repair and thus sample more activated EGFR molecules from endosomes. Here, EGFR is linked to breast carcinoma.